论文部分内容阅读
目的分析维吾尔族和汉族多发性骨髓瘤(multiple myeloma,MM)患者凝血功能差异。方法维吾尔族MM患者50例(维族组),汉族MM患者64例(汉族组),体检健康者60例(对照组),采用凝固法检测3组活化部分凝血酶时间(activated partial thromboplastin time,APTT)、凝血酶原时间(prothrombin time,PT)、凝血酶时间(thrombin time,TT)、纤维蛋白原(fibrinogen,FIB)、凝血因子Ⅷ、凝血因子Ⅸ水平,采用免疫比浊法检测3组D-二聚体(D-dimer,D-D)水平,并进行比较。结果维族组、汉族组FIB水平分别为(7.40±2.04)、(4.30±2.22)g/L,均高于对照组(2.12±0.94)g/L(P<0.05),维族组高于汉族组(P<0.05);维族组凝血因子Ⅷ水平为(96.61±19.23)%、汉族组为(96.42±17.03)%,均低于对照组(111.12±27.08)%(P<0.05),维族组与汉族组比较差异无统计学意义(P>0.05);3组APTT、PT、TT、D-D水平比较差异均无统计学意义(P>0.05)。结论 MM患者凝血功能紊乱,维吾尔族MM患者血液明显处于高凝状态。
Objective To analyze the difference of coagulation function in multiple myeloma (MM) between Uighur and Han nationality. Methods Fifty Uighur MM patients (Uygur group), 64 Han patients (Han nationality) and 60 healthy controls (control group), the activated partial thromboplastin time (APTT ), Prothrombin time (PT), thrombin time (TT), fibrinogen (FIB), coagulation factor Ⅷ and coagulation factor Ⅸ, - dimer (D-dimer, DD) levels, and compared. Results The FIB levels in Uygur and Han nationality groups were (7.40 ± 2.04) and (4.30 ± 2.22) g / L, respectively, higher than those in the control group (2.12 ± 0.94) g / L (96.61 ± 19.23)% in Uygur group and (96.42 ± 17.03)% in Han nationality group, respectively, which were significantly lower than those in control group (111.12 ± 27.08)% (P <0.05) There was no significant difference in Han group (P> 0.05). There was no significant difference in APTT, PT, TT and DD between the three groups (P> 0.05). Conclusion The coagulation disorder in patients with MM, blood in patients with Uygur MM significantly hypercoagulable state.